IMRX

3.3802.03%
LB

Laurie Bartlett Keating

Independent Chair of the Board

Ms. Laurie Bartlett Keating, JD, was Board of Kalaris Therapeutics, Inc. from August 1, 2026 She is Independent Chair of the Board of Directors at PepGen Inc. from December 2021. She had been Independent Director of Imago BioSciences, Inc. since November 17, 2021 until January 11, 2023. She served as Executive Vice President and Chief Legal Officer at Alnylam Pharmaceuticals, Inc. since March 2019 until September 10, 2021 and served as its Senior Vice President and General Counsel since September 2014 until March 2019. She served as Secretary at Alnylam Pharmaceuticals, Inc. since September 2014 until September 10, 2021. Ms. Keating served as Senior Vice President and General Counsel of Millennium Pharmaceuticals, Inc. (also known as Millennium: The Takeda Oncology Company) from September 2004 to January 2014. She served as the Chief Legal Officer and Executive Vice President of Campus Pipeline, Inc. She served as Secretary of Millennium Pharmaceuticals Inc. since September 2004 and served as its Assistant Secretary since August 2006. Ms. Keating has the legal, financial and operational experience at high technology and biotechnology companies. Ms. Keating served as Executive Vice President of operations and finance of Hydra Biosciences, Inc. which she co-founded in 2001. From 2001 to 2003, she served as the President and Chief Executive Officer of Hydra Biosciences. Ms. Keating served as Senior Vice President, General Counsel and Secretary of Iomega Corporation. She served on the executive team of Sybase Inc. for long, where she held the positions included Senior Vice President, General Counsel and Secretary. She served in senior legal and management positions with ViaCord. She began practicing law at the San Francisco, Calif. firm of McCutchen, Doyle, Brown and Enersen. She served as Director of Hydra Biosciences, Inc. from 2001 to 2007 and previously served on the board of directors of Imbria Pharmaceuticals from 2019 to 2020. She serves as a Member of the Board of Directors of MassBio. She sits on the Board of Directors for Immuneering Corporation. Based on her leadership at Sybase, Ms. Keating was named as one of the 45 most influential in-house lawyers in the United States. Ms. Keating has a Doctor of Jurisprudence from the University of California, Hastings College of the Law and a Bachelor of Arts in Economics from the University of California at Berkeley.

公司職務